OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia
Fabiana Perna, Manuel Espinoza‐Gutarra, Giuseppe Bombaci, et al.
Cancer treatment and research (2022), pp. 225-254
Closed Access | Times Cited: 11
Fabiana Perna, Manuel Espinoza‐Gutarra, Giuseppe Bombaci, et al.
Cancer treatment and research (2022), pp. 225-254
Closed Access | Times Cited: 11
Showing 11 citing articles:
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
Xavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3368-3368
Open Access | Times Cited: 12
Xavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3368-3368
Open Access | Times Cited: 12
The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands
Stefanie Maurer, Xiaoxuan Zhong, Betsy Deza Prada, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15907-15907
Open Access | Times Cited: 7
Stefanie Maurer, Xiaoxuan Zhong, Betsy Deza Prada, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15907-15907
Open Access | Times Cited: 7
Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients
Łukasz Bołkuń, Aleksandra Starosz, Anna Krętowska-Grunwald, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 462-462
Open Access | Times Cited: 1
Łukasz Bołkuń, Aleksandra Starosz, Anna Krętowska-Grunwald, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 462-462
Open Access | Times Cited: 1
T cell-mediated tumor killing sensitivity gene signature-based prognostic score for acute myeloid leukemia
Yiyun Pan, Fang‐Fang Xie, Wen Zeng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Yiyun Pan, Fang‐Fang Xie, Wen Zeng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Breaking Boundaries: Immunotherapy for Myeloid Malignancies
T. N. Gavrilova, Eduard Schulz, Alain Mina
Cancers (2024) Vol. 16, Iss. 16, pp. 2780-2780
Open Access | Times Cited: 1
T. N. Gavrilova, Eduard Schulz, Alain Mina
Cancers (2024) Vol. 16, Iss. 16, pp. 2780-2780
Open Access | Times Cited: 1
Considerations regarding maintenance therapy for acute myeloid leukemia in remission
Gary J. Schiller, Vlad Kustanovich
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-20
Open Access
Gary J. Schiller, Vlad Kustanovich
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-20
Open Access
T Cell-Mediated Tumor Killing Sensitivity Gene Signature-Based Prognostic Score For Acute Myeloid Leukemia
Yiyun Pan, Fang‐Fang Xie, Wen Zeng, et al.
Research Square (Research Square) (2024)
Open Access
Yiyun Pan, Fang‐Fang Xie, Wen Zeng, et al.
Research Square (Research Square) (2024)
Open Access
Chimeric antigen receptor T-cell therapy in acute myeloid leukaemia: Novel therapeutic approaches to longstanding challenges
H. Park, Matthew J. Simmonds, Timothy Chevassut, et al.
Gene Reports (2024) Vol. 36, pp. 101979-101979
Open Access
H. Park, Matthew J. Simmonds, Timothy Chevassut, et al.
Gene Reports (2024) Vol. 36, pp. 101979-101979
Open Access
Cytotoxic activity against human leukemia cells of Kaempferol-3-O-rhamnoside from VietnameseSchima wallichii(DC.) Korth: A combination ofin vitroandin silicoinsights
Manh Hung Tran, Yến Nhi Nguyễn, Thomas Lam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Manh Hung Tran, Yến Nhi Nguyễn, Thomas Lam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cancer Immunotherapies
Steven Rosen, Priya Hays
Cancer treatment and research (2022)
Open Access | Times Cited: 2
Steven Rosen, Priya Hays
Cancer treatment and research (2022)
Open Access | Times Cited: 2
Identification of Highly Efficacious PROTACs Targeting BRD4 Against Acute Myeloid Leukemia: Design, Synthesis, and Biological Evaluations
Aiping Chen, Yue Zhong, Yunxiao Liu, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Aiping Chen, Yue Zhong, Yunxiao Liu, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
